* Enfusion Inc ENFN.N reported quarterly adjusted earnings
of 2
cents per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for earnings
of 4 cents per share.
* Revenue was $31.85 million; analysts expected $30.41
million.
* Enfusion Inc's reported EPS for the quarter was a loss of
$2.60.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Enfusion Inc shares had fallen by 27.3% this quarter.
* The company reported a quarterly loss of $293.89 million.
* Wall Street's median 12-month price target for Enfusion
Inc is
$20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated March 25 at 06:03 a.m. All
figures in US dollars unless otherwise stated